Preoperative Cataract Pupillary Dilation: Inpatient At The Ambulatory Surgery Center vs Outpatient Dilation Prior To Arrival At The Ambulatory Surgery Center
NCT ID: NCT01169688
Last Updated: 2010-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2007-12-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery
NCT00690222
Anesthetic and Dilating Gel for Cataract Surgery
NCT00335400
Lidocaine Usage for Pupil Dilatation (Mydriasis)
NCT01170130
Optimal Method for Mydriasis in Cataract Surgery
NCT02909140
Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery
NCT03375996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pupil dilation with phenylephrine 10% vs cyclopentolate 2%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to follow and eye drop administration schedule.
* No noted ocular abnormalities.
* Bilateral cataract surgery anticipated.
Exclusion Criteria
* Health problems that would contraindicate self administration of dilating eye drops such as poor cardiovascular or respiratory status.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwest Kansas Surgery Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Northwest Kansas Surgery Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NWKSC_2007_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.